Five US states join FTC suit over alleged Hims & Hers unlawful practices

Five US states (Arizona, Florida, Nebraska, Ohio, Wisconsin) joined the FTC's lawsuit against Hims & Hers Health, alleging deceptive and unlawful privacy practices. The amended complaint also includes Utah and California. The FTC filed the original lawsuit on Tuesday.

Original reporting
Published Nov 10, 2026, 9:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefRegulation
Primary signal
$HIMS
Bearish
high confidence
Mentioned
$HIMS
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HIMSBearishHigh
01

Why it matters

Legal exposure may lead to short‑selling opportunities and heightened volatility.

02

Market read

Regulatory action against a listed telehealth firm creates immediate trading risk and sector‑wide attention.

03

What to watch

Potential for the company to negotiate a settlement or adjust privacy policies without major disruption.

Relevance 7/10Novelty 8/10Timing: today

Background

The FTC expanded its complaint to include five additional states, signaling a broader enforcement effort against Hims & Hers.

Company-level read

Ticker impact

$HIMSBearishHigh confidence
Context

The FTC filed a lawsuit alleging deceptive privacy practices by Hims & Hers Health, a new regulatory enforcement action.

Expected impact

downward pressure as investors price in regulatory risk and possible penalties

Evidence & confidence

Regulatory actions of this magnitude historically trigger sell‑offs for affected companies, especially in the telehealth sector.

Market effects

Increased scrutiny on telehealth and digital health privacy practices may affect peer companies.

US equity markets may see modest downside pressure in health‑tech stocks.

Limited to US‑listed health‑tech firms; no immediate global ripple.

Counterpoint

The lawsuit could settle quickly with minimal penalties, limiting long‑term impact.

Key entities

  • Federal Trade Commission

    U.S. agency filing the lawsuit.

  • Hims & Hers Health Inc.

    Telehealth provider accused of unlawful privacy practices.

Related articles

$HIMSMed

Five more states join FTC privacy complaint against Hims & Hers Health

The FTC and five additional states (Arizona, Florida, Nebraska, Ohio, Wisconsin) joined a complaint against Hims & Hers Health (HIMS), alleging the company shared patient health data with third-party advertisers. Utah and California were previously involved in the complaint. The case highlights potential privacy violations and regulatory risks for HIMS.

$HIMSMedAI 8/10

HIMS Q3 Earnings Call Highlights Marketing Reset and Margin Pressure

Hims & Hers Health reported Q3 2026 revenue of $890.4M (+49% YoY) and EPS of $0.03, missing estimates. The company is prioritizing weight-loss expansion and international growth over short-term subscriber gains, leading to a 100,000 sequential subscriber decline. Management cut full-year EBITDA guidance due to planned investments, while gross margins fell to 57% from 74% YoY.